{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-071249","form_type":"8-K","ticker":"TRDA","cik":"0001689375","company_name":"Entrada Therapeutics, Inc.","filed_at":"2024-06-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.590957+00:00","generated_at":"2026-06-01T04:38:15.098574+00:00","sec_items":["5.03","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Entrada Therapeutics shareholders approve officer liability limitation amendment and elect director","bullets":["Stockholders approved Certificate of Amendment to limit officer liability as permitted by Delaware law.","Gina Chapman elected as Class III director with 19,701,297 votes for, 101,960 withheld, 2,418,006 broker non-votes.","Ernst & Young LLP ratified as independent auditor for FY 2024 (22,210,935 for, 2,174 against, 8,154 abstain).","Certificate of Amendment filed with Delaware Secretary of State, effective June 13, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-071249","json":"https://secwatch.observer/filing/0001104659-24-071249.json","markdown":"https://secwatch.observer/filing/0001104659-24-071249.md","text":"https://secwatch.observer/filing/0001104659-24-071249.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1689375/000110465924071249/0001104659-24-071249-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1689375/000110465924071249/tm2417220d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T04:38:15.098574+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}